FdaApplication
ANDA 202471
Identifiers
- fda_app_no: ANDA202471
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN INSTITUTIONAL LLC |
| application_type | ANDA |
| approval_date | 2018-06-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BIVALIRUDIN | BIVALIRUDIN | 250MG/VIAL | INJECTABLE;INTRAVENOUS |
1 product